DARE - Dare Bioscience, Inc.
2.27
-0.090 -3.965%
Share volume: 458,884
Last Updated: 04-22-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$2.36
-0.09
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-14-2024 | 05-13-2025 | 08-14-2025 | 11-13-2025 | 03-26-2026 | |
| Total revenue | 9.302 K | 22.438 K | 41.691 K | 25.427 K | -21.172 K | 2.262 K | 1.024 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 295.799 K | |
| Gross profit | 9.302 K | 22.438 K | 41.691 K | 25.427 K | -21.172 K | 2.262 K | 727.877 K | |
| 141.22% | 85.81% | -39.01% | -183.27% | 110.68% | 32,078.47% | |||
| Operating expenses | 5.999 M | 7.357 M | 4.698 M | 4.607 M | 3.807 M | 3.674 M | 2.199 M | |
| Selling general and admin | 2.671 M | 2.448 M | 2.041 M | 2.309 M | 2.378 M | 2.499 M | 1.577 M | |
| Research and development | 3.329 M | 4.909 M | 2.657 M | 2.297 M | 1.429 M | 1.175 M | 622.041 K | |
| Total expenses | 6.032 M | 7.382 M | 4.723 M | 4.607 M | 3.807 M | 3.674 M | 2.199 M | |
| 22.38% | -36.02% | -2.47% | -17.36% | -3.47% | -40.15% | |||
| Operating income | -6.022 M | -7.359 M | -4.681 M | -4.581 M | -3.828 M | -3.672 M | -1.471 M | |
| Ebit | -6.755 M | -7.359 M | -4.703 M | -4.378 M | -4.016 M | -3.563 M | -1.748 M | |
| Pretax income | -6.755 M | 13.020 M | -4.703 M | -4.378 M | -4.016 M | -3.563 M | -1.748 M | |
| -292.73% | -136.12% | -6.89% | -8.26% | -11.30% | -50.94% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.755 M | 12.911 M | -4.703 M | -4.378 M | -4.016 M | -3.563 M | -1.442 M | |
| 291.12% | -136.42% | 6.89% | 8.26% | 11.30% | 59.53% |